Page last updated: 2024-10-30

mecamylamine and Cancer of Colon

mecamylamine has been researched along with Cancer of Colon in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Still, PC1
Yi, B1
González-Cestari, TF1
Pan, L1
Pavlovicz, RE1
Chai, HB1
Ninh, TN1
Li, C1
Soejarto, DD1
McKay, DB1
Kinghorn, AD1
Kikuchi, H1
Itoh, J1
Fukuda, S1

Other Studies

2 other studies available for mecamylamine and Cancer of Colon

ArticleYear
Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities.
    Journal of natural products, 2013, Feb-22, Volume: 76, Issue:2

    Topics: Alkaloids; Bridged Bicyclo Compounds, Heterocyclic; Colonic Neoplasms; HT29 Cells; Humans; Malvaceae

2013
Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor.
    Neuroscience letters, 2008, Feb-27, Volume: 432, Issue:3

    Topics: Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; GATA3 Transcription Factor; Human

2008